Back to News
Market Impact: 0.08

Pharming To Present New Leniolisib Pediatric And CVID Data At CIS 2026

PHAR
Healthcare & BiotechCompany FundamentalsTechnology & Innovation

Pharming Group N.V. will deliver multiple scientific presentations at the Clinical Immunology Society (CIS) 2026 Annual Meeting in New Orleans on May 6-9, 2026. The announcement is a routine conference update with no financial metrics, clinical results, or guidance changes. Market impact is likely limited.

Analysis

Pharming Group N.V. will deliver multiple scientific presentations at the Clinical Immunology Society (CIS) 2026 Annual Meeting in New Orleans on May 6-9, 2026. The announcement is a routine conference update with no financial metrics, clinical results, or guidance changes. Market impact is likely limited.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

neutral

Sentiment Score

0.10

Ticker Sentiment

PHAR0.20